The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers

Inge-Marie Obdeijn; Ritse M. Mann; Claudette C. E. Loo; Marc Lobbes; Eleonora M. C. Voormolen; Carolien H. M. van Deurzen; Geertruida de Bock; Maartje J. Hooning; Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON)

doi:10.1007/s10549-020-05642-1

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers

Inge-Marie Obdeijn^*, Ritse M. Mann, Claudette C. E. Loo, Marc Lobbes, Eleonora M. C. Voormolen, Carolien H. M. van Deurzen, Geertruida de Bock, Maartje J. Hooning, Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON)

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	581-588
Number of pages	8
Journal	Breast Cancer Research and Treatment
Volume	181
Issue number	3
DOIs	https://doi.org/10.1007/s10549-020-05642-1
Publication status	Published - Jun 2020

Keywords

BRCA mutation carriers
Screening
MRI
Mammography
CHROMOSOMAL RADIOSENSITIVITY
CANCER
WOMEN
RISK
SURVEILLANCE
ULTRASOUND

Access to Document

10.1007/s10549-020-05642-1

Cite this

Obdeijn, I-M., Mann, R. M., Loo, C. C. E., Lobbes, M., Voormolen, E. M. C., van Deurzen, C. H. M., de Bock, G., Hooning, M. J., & Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON) (2020). The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers. Breast Cancer Research and Treatment, 181(3), 581-588. https://doi.org/10.1007/s10549-020-05642-1

Obdeijn, Inge-Marie ; Mann, Ritse M. ; Loo, Claudette C. E. ; Lobbes, Marc ; Voormolen, Eleonora M. C. ; van Deurzen, Carolien H. M. ; de Bock, Geertruida ; Hooning, Maartje J. ; Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON). / The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers. In: Breast Cancer Research and Treatment. 2020 ; Vol. 181, No. 3. pp. 581-588.

@article{5d132318593641b68b9e39745f63d7f8,

title = "The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers",

keywords = "BRCA mutation carriers, Screening, MRI, Mammography, CHROMOSOMAL RADIOSENSITIVITY, CANCER, WOMEN, RISK, SURVEILLANCE, ULTRASOUND",

author = "Inge-Marie Obdeijn and Mann, {Ritse M.} and Loo, {Claudette C. E.} and Marc Lobbes and Voormolen, {Eleonora M. C.} and {van Deurzen}, {Carolien H. M.} and {de Bock}, Geertruida and Hooning, {Maartje J.} and {Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON)}",

year = "2020",

month = jun,

doi = "10.1007/s10549-020-05642-1",

language = "English",

volume = "181",

pages = "581--588",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer, Cham",

number = "3",

}

Obdeijn, I-M, Mann, RM, Loo, CCE, Lobbes, M, Voormolen, EMC, van Deurzen, CHM, de Bock, G, Hooning, MJ & Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON) 2020, 'The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers', Breast Cancer Research and Treatment, vol. 181, no. 3, pp. 581-588. https://doi.org/10.1007/s10549-020-05642-1

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers. / Obdeijn, Inge-Marie; Mann, Ritse M.; Loo, Claudette C. E.; Lobbes, Marc; Voormolen, Eleonora M. C.; van Deurzen, Carolien H. M.; de Bock, Geertruida; Hooning, Maartje J.; Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON).

In: Breast Cancer Research and Treatment, Vol. 181, No. 3, 06.2020, p. 581-588.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers

AU - Obdeijn, Inge-Marie

AU - Mann, Ritse M.

AU - Loo, Claudette C. E.

AU - Lobbes, Marc

AU - Voormolen, Eleonora M. C.

AU - van Deurzen, Carolien H. M.

AU - de Bock, Geertruida

AU - Hooning, Maartje J.

AU - Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON)

PY - 2020/6

Y1 - 2020/6

KW - BRCA mutation carriers

KW - Screening

KW - MRI

KW - Mammography

KW - CHROMOSOMAL RADIOSENSITIVITY

KW - CANCER

KW - WOMEN

KW - RISK

KW - SURVEILLANCE

KW - ULTRASOUND

U2 - 10.1007/s10549-020-05642-1

DO - 10.1007/s10549-020-05642-1

M3 - Article

VL - 181

SP - 581

EP - 588

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -